Nomura Instinet analyst Dan Dolev started Perficient (PRFT) with a Buy rating and $40 price target. Perficient, as a "small fish" in an $80B digital transformation pond, is well positioned between large firms like Accenture (ACN) and boutiques, Dolev tells investors in a research note. The analyst sees favorable category exposure for the company and "strong: secular tailwinds in healthcare.

IBM (IBM) is scheduled to report results of its fiscal first quarter after the market close on April 24, with a conference call scheduled for 5:00 pm ET. What to watch... To see the rest of the story go to thefly.com. See Story Here

Alliance Global Partners analyst Brian Kinstlinger upgraded Perficient to Buy from Neutral with a $67 price target. Many of the systems integrators' management teams, including Perficient, reported in February that demand was showing signs of improvement, the analyst tells investors in a research note. The firm says Perficient is now trading toward the low-end of its historical valuation range based on adjusted earnings. Given its "generally high visibility" to revenue, Alliance believes the stock's risk/reward profile is very favorable, "even if there are marginal shortfalls to consensus in the next few quarters."